Steakholder Foods Begins Cultured Pork Development Using More Scalable Porcine Cell Line
Cultivated meat company Steakholder Foods Ltd. (Nasdaq: STKH) (formerly MeaTech 3D) announces it will begin developing cultured pork products using a new line of porcine stem cells. The advancement will enable it to further diversify its portfolio and accelerate its market readiness for cultured pork production.
|“Pork has tremendous market potential …as the most popular meat in the world”
Known as iPS (induced pluripotent porcine stem cell line), the new cell line was derived from sample cells that were reprogrammed back into an embryonic-like “pluripotent” state. In this state, one cell bank can become an unlimited and highly scalable source for developing any type of muscle or fat cells for cultured meat, Steakholder says.
To achieve this, Steakholder says it has partnered with a leading iPS cell line provider to shorten the development timeline for more complex, structured pork products such as bacon, pork chops and ham.
